These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 12823348
21. Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component. Richards DB, Cookson LM, Berges AC, Barton SV, Lane T, Ritter JM, Fontana M, Moon JC, Pinzani M, Gillmore JD, Hawkins PN, Pepys MB. N Engl J Med; 2015 Sep 17; 373(12):1106-14. PubMed ID: 26176329 [Abstract] [Full Text] [Related]
23. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis. Hazenberg BP, van Rijswijk MH, Piers DA, Lub-de Hooge MN, Vellenga E, Haagsma EB, Hawkins PN, Jager PL. Am J Med; 2006 Apr 17; 119(4):355.e15-24. PubMed ID: 16564782 [Abstract] [Full Text] [Related]
24. Amyloidomas of the nervous system: a monoclonal B-cell disorder with monotypic amyloid light chain lambda amyloid production. Laeng RH, Altermatt HJ, Scheithauer BW, Zimmermann DR. Cancer; 1998 Jan 15; 82(2):362-74. PubMed ID: 9445195 [Abstract] [Full Text] [Related]
25. [Usefulness of a free light chain immunoassay in serum for the diagnosis and the follow-up of monoclonal gammopathy]. Guenet L, Decaux O, Lechartier H, Ropert M, Grosbois B. Rev Med Interne; 2007 Oct 15; 28(10):689-97. PubMed ID: 17566612 [Abstract] [Full Text] [Related]
26. New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes. Palladini G, Dispenzieri A, Gertz MA, Kumar S, Wechalekar A, Hawkins PN, Schönland S, Hegenbart U, Comenzo R, Kastritis E, Dimopoulos MA, Jaccard A, Klersy C, Merlini G. J Clin Oncol; 2012 Dec 20; 30(36):4541-9. PubMed ID: 23091105 [Abstract] [Full Text] [Related]
27. Immunoglobulin-related (AL) amyloidosis. Husby G. Clin Exp Rheumatol; 1983 Dec 20; 1(4):353-8. PubMed ID: 6442636 [Abstract] [Full Text] [Related]
28. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System. Barros-Gomes S, Williams B, Nhola LF, Grogan M, Maalouf JF, Dispenzieri A, Pellikka PA, Villarraga HR. JACC Cardiovasc Imaging; 2017 Apr 20; 10(4):398-407. PubMed ID: 27639764 [Abstract] [Full Text] [Related]
29. Immunoglobulin-free light chain monomer-dimer patterns help to distinguish malignant from premalignant monoclonal gammopathies: a pilot study. Kaplan B, Golderman S, Aizenbud B, Esev K, Kukuy O, Leiba M, Livneh A, Ben-Zvi I. Am J Hematol; 2014 Sep 20; 89(9):882-8. PubMed ID: 24866208 [Abstract] [Full Text] [Related]
30. AL amyloidosis associated with IgM paraproteinemia: clinical profile and treatment outcome. Wechalekar AD, Lachmann HJ, Goodman HJ, Bradwell A, Hawkins PN, Gillmore JD. Blood; 2008 Nov 15; 112(10):4009-16. PubMed ID: 18708629 [Abstract] [Full Text] [Related]
32. [A new approach to the determining immunoglobulin free light chains in serum by TIA nephelometry]. Wakasugi K, Suzuki H, Suzuki M. Nihon Rinsho Meneki Gakkai Kaishi; 1996 Feb 15; 19(1):87-93. PubMed ID: 8681031 [Abstract] [Full Text] [Related]
33. Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases. Tate JR, Mollee P, Dimeski G, Carter AC, Gill D. Clin Chim Acta; 2007 Feb 15; 376(1-2):30-6. PubMed ID: 16945362 [Abstract] [Full Text] [Related]
34. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis. Safadi S, Saad A, Quint PS, Sethi S, Leung N, Kurtin P, Nasr SH. Nephrol Dial Transplant; 2015 Jul 15; 30(7):1151-5. PubMed ID: 25796445 [Abstract] [Full Text] [Related]
36. The impact of renal function on the clinical performance of FLC measurement in AL amyloidosis. Palladini G, Milani P, Foli A, Basset M, Russo F, Bosoni T, Pirolini L, Valentini V, Ferraro G, Lavatelli F, Barassi A, Albertini R, Merlini G. Clin Chem Lab Med; 2016 Jun 01; 54(6):939-45. PubMed ID: 26943606 [Abstract] [Full Text] [Related]
37. Free light chain testing for the diagnosis, monitoring and prognostication of AL amyloidosis. Mollee P, Merlini G. Clin Chem Lab Med; 2016 Jun 01; 54(6):921-7. PubMed ID: 26812792 [Abstract] [Full Text] [Related]